Welcome!
The Lu group’s research interests lie at the interface between chemistry and biology. We are developing novel chemical approaches to provide deeper insight into biological structures and functions. We are also taking advantage of recently developed biological tools to advance many areas in chemistry, such as inorganic chemistry, chemical biology, analytical chemistry, organic chemistry, and materials chemistry. The integrated approach is allowing us to make significant contributions to the following areas of research:
1. Biosynthetic Inorganic Chemistry
Computational design using the latest AI-based generative protein design approaches and directed evolution of artificial metalloenzymes as environmentally benign biocatalysts for renewable energy generation and pharmaceutical drug syntheses.
2. Biocatalysis and Synthetic Biology
Engineer biocatalysts to address challenges in synthetic organic chemistry and applications of novel biocatalysts in synthetic biology for biomass conversion and valuable products generation in high yield and selectivity.
3. Bioanalytical Chemistry
Design and selection of sensors and imaging agents for metal ions, metabolites and glycoRNAs to advance spatial metallomics, metabolomics, and glycomics for medical diagnosis, imaging and therapy in neurodegenerative and infectious diseases and cancers.
4. Functional DNA Nanotechnology
Using DNA for encoded synthesis and directed assembly of nanomaterials, as well as the applications of these nanomaterials as theranostic agents for early detection of diseases such as cancers and targeted drug delivery.
5. Gene Editing/Therapy
Developing novel gene-editing methods to improve sequence fidelity and gene target accessibility.
6. Spatiotemporal Omics
Developing nucleic acid tools and methods that integrate proximity labeling, single-cell and spatial sequencing to quantitatively link different layers of omics in biological systems across space and time.
Recent News
2025 August | Yuting’s Nature Aging paper on Targeting iron-associated protein Ftl1 in the brain of old mice improves age-related cognitive impairment , in collaboration with Drs. Laura Remesal and Saul A. Villeda from University of California at San Francisco has been covered by the CNS News. Congratulations Yuting!
2025 August | Weijie’s PNAS paper titled Tandem ssDNA in neutrophil extracellular traps binds thrombin and regulates immunothrombosis has been highlighted by PNAS. In a commentary by Drs. Craig Jenne and Paul Kubes from the University of Calgary , they stated that “Molecular studies, such as those in the current work, is what is needed to provide further insight into the biological properties of NETs and the pathogenesis that can occur in conditions like sepsis and ARDS.” Congratulations Weijie!
2025 August | Congratulations to Aritra for winning the 2025 Henze Teaching Award!
2025 March | Congratulations to Casey, who will start his independent career as an assistant professor in the Department of Chemistry at Indiana University Bloomington!
2025 February | Congratulations to Whitney, who will start her new position in Kymera Therapeutics!
2025 January | Congratulations to Mandira, who will start her new position in Princeton BioLabs!
2024 December | The Lu group won the Lead Detect Prize together with GlucoSentient, Inc.
2024 December | Congratulations to Yunling, who will start her independent career as an assistant professor in the Department of Chemistry at St. Mary’s College of Maryland!
2024 December | Congratulations to Yiming, who will start her independent career as an assistant professor in the Department of Chemistry at Haverford College!
2024 August | Mandira’s work on brain imaging with fluorescence sensors using exosome delivery has been covered by ACS Newsroom.
2024 August | The Lu group, along with the groups of Thomas Cundari, Andy Ellington, Kami Hull and Mike Rose, have received a Catalyst for Discovery program grant from the Welch Foundation.
2024 May | Congratulations, Yiwei, for receiving the Summer 2024 Chemistry Department Research Fellowship!
2024 April | Whitney has won the prestigious P.E.O. Scholar Award. Congratulations, Whitney!
2024 March | The Lu group is among the winners of Phase I of the Lead Detect Prize.
2024 March | The Lu group has become an associate member of The Acquired Resistance to Therapy Network (ARTNet). We are working with Dr. Boyi Gan and others at the MD Anderson Cancer Center on developing imaging probes to gain mechanistic insights into ferroptosis and cuprotosis and using the insights to design better ferroptosis- and cuprotosis-inducing anti-cancer drugs.
2024 March | The Lu group has received a grant from CPRIT to decipher iron redox cycles in ferroptosis-based cancer therapy.
2023 August | Dr. Lu has become a member of the Institute for Neuroscience.
2023 April | Yuan and Weijie’s Nature Biotechnology paper on glycoRNA imaging got featured in CNS News.







